Boards & Committees - Annual Meeting



ANNUAL MEETING PROGRAM COMMITTEE


ANNUAL MEETING WEBSITE:
ishlt.org/meetings/annualMeeting.asp



EXECUTIVE PROGRAM COMMITTEE
The Executive Program Committee shall consist of the President, Program Chair, Immediate Past Program Chair and Incoming Program Chair whose responsibility will be to serve as the executive decision-making body of the Program Committee and to liaise with staff between meetings of the Program Committee.


A) SYMPOSIUM PLANNING COMMITTEE

Committee Composition:
  • The Annual Meeting Symposium Planning Committee shall consist of a Vice-Chair appointed by the President-Elect, subject to approval by the Board, and a Chair who shall rotate into the position after serving as Vice-Chair.  Chair and Vice-Chair terms are one year each.
  • The Immediate Past Scientific Program Committee Chair, the Editor of the Journal, the Chair of the Education Committee, and the President, shall also serve as members of the Program Committee.
  • The Chairs of the Scientific Councils shall nominate up to four individuals to be considered for appointment as members of the Annual Meeting Symposium Planning Committee. Ideally, one nominee from each Council shall be selected by the Chair to serve on the Committee.
  • The Chair shall appoint sufficient additional committee members to reflect the agreed-upon scientific and therapeutic disciplines, with no less than two and no more than four members assigned to each scientific or therapeutic discipline.  Such terms are for one year.
  • Committee members must have served as an abstract reviewer in the past.
  • Council Officers, members of Council Education Workforces, and members of the Education Committee may not serve on the Symposium Planning Committee except for the Chair of the Education Committee.
  • Other than the Past Program Chair, the Program Chair, the Immediate Past Program Chair, the Chair of the Education Committee, and the Editor of the Journal, no member of the Committee may serve more than two years consecutively.  A break of one year minimum is required.
  • The committee members must be approved by the Board in advance.
  • Every effort should be made to include both new and experienced members on the committee and to ensure gender and geographic diversity.
  • If not already an elected Board member, the Chair of the Annual Meeting Scientific Program Committee shall serve as an ex-officio member of the Board and shall also serve as a member of the Education Committee.
Committee Responsibilities:
  • Develop learning objectives for the Annual Meeting that are tied to the identified practice gaps and educational needs of the members.
  • Ensure that the Annual Meeting Symposia and other invited content addresses the identified practice gaps and educational needs of the members and the established learning objectives.
  • Develop the Annual Meeting  Symposia and other invited content.
  • Evaluate and make changes, as needed, to the format, structure, and content development process of the Annual Meeting Scientific Program.
B) ABSTRACT SELECTION COMMITTEE

Committee Composition:
  • The Annual Meeting Abstract Selection Committee shall consist of the members of the Symposium Planning Committee, plus such additional members appointed by the Chair as are necessary to ensure that there are at least two members assigned to each of the main abstract categories. Such terms are for one year.
  • Council Officers, members of Council Education Taskforces, and members of the Education Committee may not serve on the Abstract Selection Committee., except for the Chair of the Education Committee.
  • Committee members must have served as an abstract reviewer in the past.
  • Other than the Immediate Past Program Chair, the Program Chair, the Program Chair-Elect, the Chair of the Education Committee, and the Editor of the Journal no member of the Committee may serve more than two years consecutively.  A break of one year minimum is required.
  • Every effort should be made to include both new and experienced members on the committee and to ensure gender and geographic diversity.
Committee Responsibilities:
  • Review and select submitted abstracts for presentation at the Annual Meeting.
  • Develop the abstract sessions for presentation at the Annual Meeting.
  • Select finalists and/or recipients for the various ISHLT abstract awards.
  • Ensure that the abstract content of the Annual Meeting addresses the identified practice gaps and educational needs of the members and the established learning objectives.
  • Evaluate and make changes, as needed, to the format, structure, and content development process of the Annual Meeting Scientific Program.
A = Symposium Planning Committee
B = Abstract Selection Committee



2018 EXECUTIVE PROGRAM COMMITTEE:

Christian benden2018 SCIENTIFIC PROGRAM CHAIR
Christian Benden, MD FCCP (A & B)
University Hospital Zurich
Zurich, SWITZERLAND
christian_benden@yahoo.de

Christian Benden is the Medical Director of Lung Transplantation at the University Hospital Zurich and a Reader in Pulmonology and Transplant Medicine at the University of Zurich, Switzerland. He completed his pediatric training in Hannover (Germany) and London (United Kingdom). He trained in Pediatric Pulmonology and received specialist training in lung transplantation in London and Zurich. Dr. Benden’s research interests include clinical aspects of lung transplantation, particularly in children, experimental aspects of chronic lung graft dysfunction, and cystic fibrosis lung disease.


Andrew fisherISHLT PRESIDENT
Andrew J. Fisher, FRCP, PhD (A & B)
Freeman Hospital
Newcastle Upon Tyne, UK
a.j.fisher@ncl.ac.uk

Andrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as a Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.


lara danziger-isakov2019 SCIENTIFIC PROGRAM CHAIR
Lara Danziger-Isakov, MD, MPH (A & B)
Children's Hospital Medical Center
Cincinnati, OH, USA
lara.danziger-isakov@cchmc.org

Lara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is Associate Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and complete her residency in Pediatrics at the Cleveland Clinic. She also completed a fellowship in Pediatric Infectious Diseases at Saint Louis Children's Hospital. Dr. Danziger-Isakov is board-certified in Pediatrics and Pediatric Infectious Diseases by the American Board of Pediatrics. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on pediatric and adult lung transplantation. In addition, Dr. Danziger-Isakov participates in clinical trials to evaluate both new infectious disease therapies and new method of detection for infectious diseases.


Jeffrey teuteberg2017 SCIENTIFIC PROGRAM CHAIR
Jeffrey J. Teuteberg, MD (A & B)
Stanford University School of Medicine
Stanford, CA, USA
650-725-3798
jteut@stanford.edu

Dr. Jeffrey Teuteberg is an Associate Professor of Medicine in the Heart and Vascular Institute, Heart Failure/Transplantation, at the University of Pittsburgh, and the Medical Director for Advanced Heart Failure. Dr. Teuteberg joined the Cardiovascular Institute in 2004 after completing his training in Heart Failure and Cardiac Transplantation at Brigham and Women's Hospital in Boston. He graduated from the University of Chicago, Pritzker School of Medicine in 1992 and remained at the University of Chicago for his Internal Medicine Residency and General Cardiovascular Fellowship, during which he spent a year as the Chief Medical Resident. Dr. Teuteberg’s research interests include ventricular assist devices, and cardiac transplantation.


Jeffrey teutebergISHLT STAFF LIAISON
Susie Newton
ISHLT Headquarters
Addison, TX, USA
972-490-9495
susie.newton@ishlt.org

2018 PROGRAM COMMITTEE MEMBERS
(by group)


BASIC SCIENCE AND TRANSLATIONAL RESEARCH (BSTR):

Howard J. Eisen, MD (LIAISON) (A & B)
Drexel University College of Medicine
Philadelphia, PA, USA
heisen@drexelmed.edu

Andrew J. Fisher, FRCP, PhD (A & B)
Freeman Hospital
Newcastle Upon Tyne, UK

Stijn Verleden, PhD (A & B)
KU Leuven
Leuven, BELGIUM

Chris Wigfield, MD, FRCS (A & B)
Advocate Christ Medical Center
Chicago, IL, USA

ECONOMICS, ETHICS, PUBLIC POLICY (EEP):

Stephen C. Clark, FRCS (LIAISON) (B)
Freeman Hospital
Newcastle upon Tyne, UK
s.c.clark@ncl.ac.uk

Ashish Shah, MD (B)
Vanderbilt University
Nashville, TN, USA

HEART FAILURE (HF):

Savitri Fedson, MD (LIAISON) (B)
Baylor College of Medicine
Houston, TX, USA
fedson@bcm.edu

Sharon Chih, MD (B)
University of Ottawa Heart Institute
Ottawa, ON, CANADA

Ivan Knezevic, MD (B)
University Clinical Center
Ljubljana, SLOVENIA

HEART TRANSPLANTATION (HTX):

Marian Urban, MD (LIAISON) (A & B)
Freeman Hospital
Newcastle Upon Tyne, UK
murban@doctors.net.uk

Francisco Arabia, MD (B)
Cedars-Sinai Heart Institute
Los Angeles, CA, USA

Alexander Bernhardt, MD (A & B)
University Heart Center Hamburg
Hamburg, GERMANY

Teresa De Marco, MD, FACC (A & B)
University of California, San Francisco
San Francisco, CA, USA

Marco Masetti, MD, PhD (B)
University of Bologna
Bologna, ITALY

Jorge Silva Enciso, MD (A & B)
University of California San Diego
San Diego, CA, USA

INFECTIOUS DISEASES (ID):

Saima Aslam, MD, MS (LIAISON) (A & B)
UCSD
San Diego, CA, USA
saslam@ucsd.edu

Orla Morrissey, MD (A & B)
The Alfred Hospital
Melbourne, AUSTRALIA

Macé Schuurmans, MD (A & B)
University of Zurich
Zurich, SWITZERLAND

JUNIOR FACULTY CLINICAL CASE REPORTS (CASE)

Joshua Mooney, MD (LIAISON) (B)
Stanford University
Palo Alto, CA, USA
jjmooney@stanford.edu

Agnieszka Ciarka, MD (B)
KU Leuven
Leuven, BELGIUM

Sitaramesh Emani, MD (B)
The Ohio State University
Columbus, OH, USA

Thenappan Thenappan, MD (B)
University of Minnesota
Minneapolis, MN, USA

LUNG TRANSPLANTATION (LTX):

Are Martin Holm, MD, PhD (LIAISON) (A & B)
Oslo University Hospital
Oslo, NORWAY
a.m.holm@medisin.uio.no

Marcelo Cypel, MD (B)
University of Toronto
Toronto, ON, CANADA

Mark Greer, MB Bch (B)
Hannover Medical School
Hannover, GERMANY

Matthew Hartwig, MD (A & B)
Duke University
Durham, NC, USA

Monique Malouf, FRACP (A & B)
St. Vincent's Hospital
Sydney, AUSTRALIA

Keith Wille, MD, MSPH (A & B)
University of Alabama
Birmingham, AL, USA

MECHANICAL CIRCULATORY SUPPORT:

Ulrich Jorde, MD (LIAISON) (A & B)
Montefiore Medical Center
Bronx, NY, USA
ujorde@montefiore.org

Ranny Goldwasser, MD (A & B)
University Children's Hospital Heidelberg
Heidelberg, GERMANY

Jason Katz, MD, MHS (B)
University of North Carolina
Chapel Hill, NC, USA

Mary Keebler, MD (B)
Vanderbilt University
Nashville, TN, USA

Ahmet Kilic, MD (B)
The Ohio State University
Columbus, OH, USA

Antonio Loforte, MD, PhD (B)
University of Bologna
Bologna, ITALY

Sanem Nalbantgil, MD (A & B)
Ege Universite Tip Hospital
Izmir, TURKEY

Jeffrey J. Teuteberg, MD (A & B)
Stanford University
Palo Alto, CA, USA

NURSING / ALLIED HEALTH:

Quincy Young, PhD, RPsych (LIAISON) (A & B)
St. Paul's Hospital
Vancouver, BC, CANADA
qyoung@providencehealth.bc.ca

Nancy Blumenthal, CRNP (B)
University of Pennsylvania
Philadelphia, PA, USA,br>
Rachel Crackett, MSc (A & B)
Freeman Hospital
Newcastle Upon Tyne, UK

PATHOLOGY:

Alexandra Rice, FRCPath (LIAISON) (A & B)
Royal Brompton Hospital
London, UK
a.rice@rbht.nhs.uk

Carmela Tan, MD (A & B)
Cleveland Clinic
Cleveland, OH, USA

PEDIATRICS:

Melanie Everitt, MD (LIAISON) (A & B)
Children's Hospital Colorado
Aurora, CO, USA
melanie.everitt@childrenscolorado.org

Lara Danziger-Isakov, MD, MPH (A & B)
Children's Hospital Medical Center
Cincinnati, OH, USA

Melinda Solomon, MD, FRCPC (B)
Hospital for Sick Children
Toronto, ON, CANADA

PHARMACY AND PHARMACOLOGY:

Michael Shullo, PharmD (LIAISON) (A & B)
University of Pittsburgh Medical Center
Pittsburgh, PA, USA
shulloma@upmc.edu

Kyle Dawson, PharmD, MBA, BCPS (B)
Houston Methodist Hospital
Houston, TX, USA

Rochelle Gellatly, PharmD (A & B)
Alfred Hospital
Melbourne, AUSTRALIA

PULMONARY HYPERTENSION:

Marc Simon, MD (LIAISON) (A & B)
University of Pittsburgh
Pittsburgh, PA, USA
simonma@upmc.edu

Raymond Benza, MD (CTEPH LIAISON) (A & B)
Allegheny General Hospital
Pittsburgh, PA, USA
rbenza@wpahs.org

Mandeep R. Mehra, MD, MBBS, FACC, FACP (Journal Editor) (A & B)
Brigham & Women's Hospital
Boston, MA, USA
617-732-8535

Mitesh Thakrar, MD (A & B)
University of Calgary
Calgary, CANADA

Text SizeIncrease Font SizeDecrease Font Size